Morgan Stanley’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.42K Hold
17,707
﹤0.01% 7014
2025
Q1
$5.05K Hold
17,707
﹤0.01% 6991
2024
Q4
$5.95K Sell
17,707
-50
-0.3% -$17 ﹤0.01% 6960
2024
Q3
$7.58K Buy
17,757
+16,897
+1,965% +$7.21K ﹤0.01% 6793
2024
Q2
$373 Hold
860
﹤0.01% 7253
2024
Q1
$344 Sell
860
-860
-50% -$344 ﹤0.01% 7270
2023
Q4
$482 Buy
1,720
+910
+112% +$255 ﹤0.01% 7286
2023
Q3
$291 Hold
810
﹤0.01% 7361
2023
Q2
$252 Hold
810
﹤0.01% 7435
2023
Q1
$275 Hold
810
﹤0.01% 7495
2022
Q4
$258 Sell
810
-100
-11% -$32 ﹤0.01% 7620
2022
Q3
$0 Sell
910
-501
-36% ﹤0.01% 7786
2022
Q2
$1K Sell
1,411
-38
-3% -$27 ﹤0.01% 7683
2022
Q1
$1K Buy
1,449
+39
+3% +$27 ﹤0.01% 7845
2021
Q4
$1K Hold
1,410
﹤0.01% 7871
2021
Q3
$2K Buy
1,410
+910
+182% +$1.29K ﹤0.01% 7666
2021
Q2
$1K Hold
500
﹤0.01% 7613
2021
Q1
$1K Sell
500
-1,002
-67% -$2K ﹤0.01% 7348
2020
Q4
$2K Sell
1,502
-3,248
-68% -$4.33K ﹤0.01% 6892
2020
Q3
$5K Buy
4,750
+1,000
+27% +$1.05K ﹤0.01% 6440
2020
Q2
$2K Buy
3,750
+1,250
+50% +$667 ﹤0.01% 6448
2020
Q1
$1K Hold
2,500
﹤0.01% 6462
2019
Q4
$2K Sell
2,500
-76
-3% -$61 ﹤0.01% 6501
2019
Q3
$2K Buy
2,576
+76
+3% +$59 ﹤0.01% 6480
2019
Q2
$4K Sell
2,500
-27,650
-92% -$44.2K ﹤0.01% 6350
2019
Q1
$63K Buy
+30,150
New +$63K ﹤0.01% 5563
2018
Q4
Sell
-725
Closed -$5K 6648
2018
Q3
$5K Buy
+725
New +$5K ﹤0.01% 6445
2013
Q3
Sell
-22,294
Closed -$35K 5353
2013
Q2
$35K Buy
+22,294
New +$35K ﹤0.01% 5232